# Sandoz inaugurates oncology manufacturing plant in Kalwe, India

Sandoz Technical Operations, a Novartis division, inaugurated a new manufacturing plant for oral cancer medicines at Kalwe in Mumbai, India. The facility spans 32,000 sq mt, currently employs 70 people with plans to recruit 200 more, and will produce Olaparib, Darolutamide and Lenvatinib for global export.

- Type: New facility
- Announced: 2022-06-30
- Where: Kalwe, Mumbai, Maharashtra, India
- Jobs: 200
- Starts operating: 30 Jun 2022
- Status: completed
- Products: oral cancer medicines, Olaparib tablets, Darolutamide tablets, Lenvatinib capsules
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sandoz](https://endata.com/companies/55313.md)
- [Novartis](https://endata.com/companies/32041.md) (partner)

## Sources

- [indiamedtoday.com](https://indiamedtoday.com/sandoz-technical-operations-launches-manufacturing-plant-in-maharashtra/), 2022-06-30: "The new facility will produce medicines focused in the areas of oncology, covering both cancer and blood disorders."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.